Overview
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Completed
Trial end date:
2008-08-01
2008-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study will compare the safety and efficacy of Bimatoprost and Latanoprost in patients with glaucoma or ocular hypertensionPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AllerganTreatments:
Bimatoprost
Latanoprost
Ophthalmic Solutions
Tetrahydrozoline
Criteria
Inclusion Criteria:- Ocular hypertension or chronic glaucoma
- Patient requires IOP-lowering therapy in both eyes
Exclusion Criteria:
- Uncontrolled medical conditions
- Hypersensitivity to study medications